The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Todays Updates


More Time in Target Blood Pressure Range Cuts Recurrent Stroke After Intracerebral Hemorrhage Marco Meglio


A pooled analysis of 4 randomized trials found that more time with blood pressure below 130 mmHg after intracerebral hemorrhage reduced recurrent stroke risk.

FDA Accepts Troriluzole NDA Resubmission for Spinocerebellar Ataxia Marco Meglio


The FDA set a first quarter 2027 goal date for troriluzole in spinocerebellar ataxia and plans an advisory committee after a 2025 complete response letter.

Why PAD Goes Undetected in Advanced CKD, With Pranav Garimella, MBBS, MPH Pranav Garimella, MBBS, MPH


Calcified vessels may mask PAD on ankle brachial index testing, and Garimella says nephrologists can help catch it earlier.

AI Alerts Did Not Reduce Kidney Events, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS


In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

What MEnD-AKI Revealed About AI Alerts, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS


In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

Sleeve Gastrectomy Improves Heart, Kidney MRI Markers in Youth-Onset T2D Phoom Narongkiatikhun, MD


Phoom Narongkiatikhun, MD, discusses sleeve gastrectomy reducing LV mass, kidney volume, and albuminuria and boosting medullary FSOC in youth-onset T2D.

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis


Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

Todays Updates


More Time in Target Blood Pressure Range Cuts Recurrent Stroke After Intracerebral Hemorrhage Marco Meglio


A pooled analysis of 4 randomized trials found that more time with blood pressure below 130 mmHg after intracerebral hemorrhage reduced recurrent stroke risk.

FDA Accepts Troriluzole NDA Resubmission for Spinocerebellar Ataxia Marco Meglio


The FDA set a first quarter 2027 goal date for troriluzole in spinocerebellar ataxia and plans an advisory committee after a 2025 complete response letter.

Why PAD Goes Undetected in Advanced CKD, With Pranav Garimella, MBBS, MPH Pranav Garimella, MBBS, MPH


Calcified vessels may mask PAD on ankle brachial index testing, and Garimella says nephrologists can help catch it earlier.

AI Alerts Did Not Reduce Kidney Events, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS


In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

What MEnD-AKI Revealed About AI Alerts, With Sandra Kane-Gill, PharmD, MS Sandra Kane-Gill, PharmD, MS


In the MEnD-AKI trial, pharmacists reviewed deep learning predictions of AKI risk across 38 hospital service clusters at 8 hospitals.

Sleeve Gastrectomy Improves Heart, Kidney MRI Markers in Youth-Onset T2D Phoom Narongkiatikhun, MD


Phoom Narongkiatikhun, MD, discusses sleeve gastrectomy reducing LV mass, kidney volume, and albuminuria and boosting medullary FSOC in youth-onset T2D.

Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis


Tenapanor Lowers Serum Phosphate Regardless of Binder Use in Dialysis

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

2.

Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia

3.

3D Mammography Improves Long-Term Cancer Risk Prediction

4.

Breast cancer prevention: How nurse practitioners and physician assistants can help

5.

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot